Clinical Trial Update: A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a long-term safety study of tazemetostat in adults who previously received the drug in earlier trials across multiple ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Epithelioid Sarcoma
• Follicular Lymphoma
• Mesothelioma
• Non-hodgkin Lymphoma
• Renal Medullary Carcinoma
• Solid Tumors
• Synovial Sarcoma

Drugs mentioned

• TAZVERIK (TAZEMETOSTAT)

Snippet

Sponsor: Epizyme, Inc. | Conditions: Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) | Phase 1, Phase 2 | Status: COMPLETED